Lp(a) is an atherogenic lipoprotein formed by a covalent linkage of apo(a) to apoB-100 on LDL. Both Lp(a) and free apo(a) are present in plasma, as well as 80-240 kDa apo(a) fragments in plasma and urine. The present study compares the in vivo metabolism of Lp(a) and free apo(a). Lp(a) and apo(a) were purified by zonal rate ultracentrifugation followed by lysine-Sepharose chromatography from a control and a single isoform of 391kDa was used in the kinetic studies. Purified 125I apo(a) and 131I Lp(a) from the normal were injected into two control subjects and the plasma decay curve obtained over 14 days. The FCR of Lp(a) and apo(a) were 0.49+/-0.01d-1 and 0.20+/-0.01d-1 respectively establishing that the plasma catabolism of apo(a) was much slower than Lp(a). At 10 min 38% of the injected 125apo(a) was found in the Lp(a) fraction(d1.05-1.10 g/ml) and 50% free in the bottom (d>1.21 g/ml). The plasma percentage of 125I apo(a) progressively increased in Lp(a) and decreased in the d>1.21 fraction; after 24 hrs 80% and 20% of 125I apo(a) was in the Lp(a) and d>1.21 fraction respectively. In contrast, at 10 min 95% of 131I Lp(a) was present in Lp(a) (1.05-1.10 g/ml) after which there was a progressive shift with 20% of the 131I found in the free apo(a) (d>1.21 g/ml) fraction and 10% in the LDL (1.019-1.05 g/ml) fraction after 36 hrs. Over the 14 days study >99% of the urinary radioactivity was either free iodine or TCA soluble indicating that only a very small fraction of apo(a) is catabolized and secreted as large fragments in the urine. In summary: 1)Free apo(a) is catabolized much slower than Lp(a). 2)Free apo(a) in plasma. 3)During metabolism Lp(a) can be converted to apo(a) and LDL. 4)Catabolism and urinary secretion of large apo(a) fragments generated from free apo(a) or Lp(a) is a minor catabolic pathway in man. - Human Subjects
